ProCE Banner Activity

Current Data for Anti-CD20xCD3 Bispecific Antibodies for Relapsed or Refractory DLBCL

Slideset

Slides from a live webinar covering the current and emerging data for anti-CD20xCD3 bispecific antibody therapies for relapsed/refractory DLBCL.

Released: September 25, 2024

Expiration: September 24, 2025

Share

Faculty

Kathleen Dorritie

Kathleen Dorritie, MD

Assistant Professor of Medicine
Division of Hematology Oncology
UPMC, University of Pittsburgh
Pittsburgh, Pennsylvania

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Clinical Care Options, LLC and Practicing Clinicians Exchange (PCE)

ProCE Banner

Supporters

Supported by an educational grant from Genmab US, Inc.

Genmab US, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner